By Conjoint Professor David goldstein

Conference Papers

Symons R; Lau D; Freckelton J; Tebbutt N; Iatropoulos G; Dean A; Robinson M; Singhal N; Goldstein D, 2024, 'Real world experience with gemcitabine, cisplatin and durvalumab for first line treatment of advanced biliary tract cancers in Australia - Preliminary results', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 197 - 198

Yeung N; Lin H-M; Timmins H; Li T; Goldstein D; Friedlander M; Harrison ML; Mahon KL; Meikle P; Park S; Horvath L, 2023, 'Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Michael M; Wong R; Gill SS; Strickland AH; Pavlakis N; Shapiro JD; Link E; Farrell M; Ngan SY; Heriot AG; Goldstein D; Mitchell C; Wilson K; Mui M; Ramsay RG; Segelov E, 2023, 'The Ave-Rec trial: Phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer-Toxicity and interim efficacy data', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2023 - 06 June 2023

Hosen SMZ; Xu Z; Mekapogu AR; Perera C; Goldstein D; Pirola R; Wilson J; Buckley BJ; Ranson M; Apte M, 2023, 'Inhibition of urokinase plasminogen activator combined with gemcitabine enhances immune regulation and eradicates metastasis in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 31 - 32

Kokkinos J; Sharbeen G; Haghighi KS; Youkhana J; Raina A; Pitiyarachchi O; Truong Q; Wenholz D; Laczka O; Kumar N; Goldstein D; Phillips PA, 2022, 'CRO-67 is a novel therapeutic for pancreatic cancer: Implications for tumor and stromal reprogramming.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, pp. 161 - 161, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 13 September 2022 - 16 September 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899825600205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kokkinos J; Sharbeen G; Youkhana J; Boyer C; Goldstein D; Haghighi KS; McCarroll JA; Phillips PA, 2022, 'ßIII-Tubulin is a brake on extrinsic cell-death in pancreatic cancer.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, pp. 108 - 109, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 13 September 2022 - 16 September 2022

Li T; Timmins H; Trinh T; Horvath L; Harrison M; Grimison P; Kiernan M; Goldstein D; Park S, 2022, 'LONGITUDINAL TRAJECTORIES OF CLINICAL, NEUROLOGICAL AND PATIENT-REPORTED CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY FOLLOWING TREATMENT COMPLETION', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. S169 - S169, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000822950200350&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Papadopoulos L; Georgiou CL; Kee D; Caldwell R; Bourne A; Haurat J; Turner M; Goldstein D; Scott CL, 2022, 'The psychosocial impact of the Australian Rare Cancer Portal on patients with rare cancer.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 03 June 2022 - 07 June 2022

Georgiou CL; Kee D; Papadopoulos L; Caldwell R; Bourne A; Haurat J; Turner M; Goldstein D; Scott CL, 2022, 'Two years of the Australian Rare Cancer Portal: a national referral service for rare cancer information and research.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, pp. E18581 - E18581, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 03 June 2022 - 07 June 2022

Mahfouz F; Li T; Timmins H; Goldstein D; Park S, 2022, 'IMPACT OF PAIN ON SYMPTOM BURDEN IN CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. S86 - S86

Ali A; Papadopoulos L; Goldstein D; Riordan S; Wong W; Weltman M; Lim R; McEvoy C; Fellowes A; Fox S; Hofmann O; Zhu L; Vissers J; Grimmond S; Ratnayake G; Christie M; Mitchell C; Papenfuss T; Kee D; Scott C; Barker H, 2022, 'Molecular analysis of hepatic epithelioid haemangioendothelioma case series in the Stafford Fox rare cancer program and literature review', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 29 - 30

Papadopoulos LA; Georgiou CL; Kee D; Reece C; Helen K; Allison B; Javier H; Turner M; Goldstein D; Scott C, 2022, 'Patient vignettes reflecting the impact of The Australian Rare Cancer Portal on patients with Rare Cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 182 - 183

Georgiou CL; Ke H; Papadopoulos LA; Kee D; Caldwell R; Haurat J; Bourne A; Turner M; Goldstein D; Scott C, 2022, 'The Australian Rare Cancer Portal: Outcomes from the implementation of a national rare cancer platform for referrals and research', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 58 - 59

Georgiou C; Kee D; Ke H; Papadopoulos L; Haurat J; Turner M; Goldstein D; Scott C, 2022, 'The first one thousand patients: Demographics of the Australian rare cancer portal 2019-2022', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 35 - 36

Lemech C; Dredge K; Bampton D; Hammond E; Clouson A; Waterhouse N; Stanley A; Leveque-ElMouttie L; Chojnowski G; Haydon A; Pavlakis N; Burge M; Brown M; Goldstein D, 2021, 'A PHASE IB EXPANSION COHORT OF PIXATIMOD PLUS NIVOLUMAB IN PREVIOUSLY TREATED, MICROSATELLITE STABLE METASTATIC COLORECTAL CANCER (MSS MCRC)', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A367 - A367, http://dx.doi.org/10.1136/jitc-2021-SITC2021.341

Lemech C; Dredge K; Bampton D; Hammond E; Stanley A; Leveque-ElMouttie L; Chojnowski G; Haydon A; Pavlakis N; Burge M; Brown M; Goldstein D, 2021, 'A PHASE IB STUDY OF THE SAFETY AND TOLERABILITY OF PIXATIMOD PLUS NIVOLUMAB IN SUBJECTS WITH ADVANCED SOLID TUMORS WITH AN EXPANSION COHORT IN METASTATIC PANCREATIC ADENOCARCINOMA (MPDAC)', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A366 - A366, http://dx.doi.org/10.1136/jitc-2021-SITC2021.340

Scott CL; Lim R; Kee D; Georgiou C; Caldwell R; Papadopoulos L; Krasovitsky MS; Tay R; Bourne A; Vandenberg C; Dall G; Shield-Artin K; Carmagnac A; Ratnayak G; Tram J; Zhou W; Bedo J; Penington J; Zhu L; Vissers J; Thomas D; Grimmond S; Wakefield M; Papenfuss T; Barke H; Goldstein D, 2021, 'Delivering personalized care and research for rare cancers in the increasingly genomic world?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2021, 'Effectively communicating comprehensive tumour genomic profiling results: Mitigating uncertainty for advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500295&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2021, 'Psychological outcomes in advanced cancer patients after receiving genomic tumour profiling results', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Caldwell R; Georgiou C; Kee D; Papadopoulos L; Krasovitsky M; Tay R; Bourne A; Turner M; Goldstein D; Scott C, 2021, 'The Australian Rare Cancer Portal: A retrospective review of referring oncologist's service requests', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Li T; Timmins HC; Trinh T; Mizrahi D; Horvath LG; Grimison P; Harrison M; Rutherford C; King M; Kiernan MC; Goldstein D; Park SB, 2021, 'A psychometric comparison of three approaches to chemotherapy-induced peripheral neuropathy assessment: Patient report, clinical grading, and sensory function', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. S96 - S96, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000712224700205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Li T; Timmins H; Trinh T; Kiernan M; Goldstein D; Park S, 2021, 'Multifaceted approach to profiling vincristine-induced peripheral neuropathy', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. 360 - 360, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000696233800123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mekapogu A; Xu Z; Pothula S; Perera C; Pang T; Hosen SMS; Damalanka V; Mahoney V; Janekta J; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte M; Perera C, 2021, 'Hepatocyte growth factor/c-MET inhibition plus chemotherapy improves tumor immunity and eliminates metastasis in pancreatic cancer', Virtual, presented at Australian Gastroenterology Week, Virtual, 10 August 2021

Mekapogu AR; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka VC; Mahoney M; Janetka JW; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte MV, 2021, 'HEPATOCYTE GROWTH FACTOR/ C-MET PATHWAY INHIBITION COMBINED WITH CHEMOTHERAPY RETARDS PRECURSOR PANINS AND POTENTIATES LOCAL IMMUNITY IN A TRANSGENIC MODEL OF EARLY PANCREATIC CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, pp. S45 - S45, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000104&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chiang JCB; Khou V; Tavakoli A; Goldstein D; Krishnan AV; Markoulli M, 2021, 'Corneal inferior whorl morphology and reproducibility with in-vivo confocal microscopy in peripheral neuropathy', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, ELECTR NETWORK, presented at ARVO Imaging in the Eye Conference, ELECTR NETWORK, 13 May 2021 - 14 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720324200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pavlakis N; Shitara K; Sjoquist K; Martin AJ; Jaworski A; Yip S; Oh D-Y; Moehler M; Chen L-T; Bekaii-Saab T; Simes J; Goldstein D, 2021, '1438TiP INTEGRATE IIb: A randomised phase III open label study of regorafenib + nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)', in Annals of Oncology, Elsevier, pp. s1074, http://dx.doi.org/10.1016/j.annonc.2021.08.1547

Bekaii-Saab T; Okusaka T; Goldstein D; Oh D-Y; Ueno M; Ioka T; Fang W; Anderson EC; Noel MS; Reni M; Choi HJ; Goldberg J; Oh SC; Li C-P; Tabernero J; Li J; Foos E; Oh C; Van Cutsem E, 2021, '1466P Napabucasin + nab-paclitaxel with gemcitabine in patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC): Results from the phase III CanStem111P study', in Annals of Oncology, Elsevier, pp. s1084 - s1085, http://dx.doi.org/10.1016/j.annonc.2021.08.794

Mekapogu AR; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka VC; Mahoney M; Janetka JW; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte MV, 2021, '184 HEPATOCYTE GROWTH FACTOR/ C-MET PATHWAY INHIBITION COMBINED WITH CHEMOTHERAPY RETARDS PRECURSOR PANINS AND POTENTIATES LOCAL IMMUNITY IN A TRANSGENIC MODEL OF EARLY PANCREATIC CANCER', in Gastroenterology, Elsevier, pp. s - 45, http://dx.doi.org/10.1016/s0016-5085(21)00855-6

Mahfouz F; Mizrahi D; Park S; Li T; Timmins H; Goldstein D, 2021, 'Examination of electrochemical skin conductance in chemotherapy-treated patients: Association with neuropathy status', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. 396 - 396

Hosen SMZ; Haar J; Xu Z; Perera C; Buckley BJ; Mekapogu AR; Pang TC; Pothula S; Ranson M; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Targeting the urokinase plasminogen activator (uPA) pathway inhibits pancreatic cancer progression', in Pancreatology, Elsevier, pp. s73, http://dx.doi.org/10.1016/j.pan.2021.05.196

Lippa N; Bier L; Revah-Politi A; Kushary ST; May H; Alkelai A; Baugh E; Hostyk J; Sands T; Bazil C; Harms M; Carmel J; Kernie S; Motelow J; Kuo S-H; Milner J; Alcalay R; Anyane-Yeboa K; Aggarwal V; Goldstein D, 2021, 'Whole exome sequencing across clinical specialties within a medical center', in MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS INC ELSEVIER SCIENCE, pp. S226 - S227

Tay R; Kee D; Black M; Haurat J; Turner M; Goldstein D; Scott C, 2020, 'The Australian Rare Cancer Portal - A national framework for co-ordinating streamlined access to rare cancer clinical expertise and research', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 206 - 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000790145400327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Pancreatic cancer-related diabetes: Do pancreatic stellate cell and cancer cell derived exosomes play a role?', in Pancreratology, presented at European Pancreatic Club

Reni M; Riess H; O'Reilly EM; Reeves JA; Chiorean E; George TJ; Scheithauer W; Pascal A; Lerch M; Brenner WS; Ko Y-J; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Biankin A; Tempero MA, 2020, 'Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020

Reni M; Riess H; O'Reilly EM; Park JO; Hatoum H; Saez BL; Salminen T; Oettle H; Lopez R; Dowden SD; Karthaus M; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Tempero MA, 2020, 'Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'I. Pancreatic Stellate Cell and Cancer Cell Derived Exosomes Impair Beta Cell Function: Implications for Pancreatic Cancer Related Diabetes', in Gastroenterology, Elsevier, Chicago, USA, presented at Digestive Disease Week, Chicago, USA, 02 May 2020, http://dx.doi.org/10.1016/S0016-5085(20)31245-2

Chiang JCB; Goldstein D; Trinh T; Au K; Krishnan AV; Markoulli M, 2020, 'The relationship between the Ocular Surface Disease Index and conventional assessments of chemotherapy-induced peripheral neuropathy', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, ELECTR NETWORK, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), ELECTR NETWORK, 01 May 2020 - 07 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000554528301316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, 'PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, TX, Austin, pp. S221 - S221, presented at Crohn's and Colitis Congress, TX, Austin, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349500565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sahai V; Tabernero J; Van Cutsem E; Reni M; Tempero MA; O'Reilly EM; Berlin J; Riess H; Goldstein D; Li M; Lu B; Ferrara S; Philip PA, 2020, 'Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020

Pang T; Mekapogu AR; Xu Z; Pothula S; Goldstein D; Pirola R; Wilson J; Becker T; Apte M, 2020, 'Characterization of circulating pancreatic stellate cells in pancreatic cancer by single-cell transcriptomic analysis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 161 - 162

Best M; Butow P; Davies G; Napier C; Bartley N; Ballinger M; Biesecker BB; Juraskova I; Meiser B; Schlub T; Thomas D; Goldstein D, 2020, 'How much do cancer patients value whole genome sequencing? A cross-sectional survey using the willingness-to-pay technique', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, pp. 790 - 790

Mekapogu A; Xu Z; Pothula S; Perera C; Pang T; Hosen Z; Janetka J; Damalanka V; Mahoney M; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Inhibition of both the ligand and receptor of the hepatocyte growth factor/c-MET pathway, in combination with chemotherapy, retards progression of PanIN lesions in KPC mice', in Pancreatology, Elsevier, pp. s39 - s40, http://dx.doi.org/10.1016/j.pan.2020.07.049

Butow P; Best M; Davies G; Schlub T; Napier C; Bartley N; Ballinger M; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas D, 2020, 'Psychological impact of comprehensive genomic profiling results to advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92

Hale J; Evans A; Aughton K; Elander NO; Ghaneh P; Neoptolemos JP; Jackson R; Cox TF; Campbell F; Halloran CM; Mackey JR; Scarfe AG; Valle JW; Carter R; Cunningham D; Tebbutt NC; Goldstein D; Shannon J; Glimelius B; Deakin M; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Costello E; Palmer DH; Buechler MW; Greenhalf W, 2019, 'hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1436 - 1437, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000505712800168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee B; Shapiro J; Thomson B; Ananda S; Lipton L; McLachlan S-A; Wong R; Cooray P; Burge M; Clarke K; Pattison S; Nikfarjam M; Tebbutt N; Harris M; Croagh D; Goldstein D; Nagrial A; Zielinski R; Roy A; Chee CE; Putoczki T; Hollande F; Hofmann O; Vissers J; Grimmond S; Gibbs P, 2019, 'How can digital health be used to improve outcomes in pancreatic ductal adenocarcinoma (PDAC)? Examining the potential of the PURPLE translational pancreatic cancer platform', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 73 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Z; Pang T; Pothula S; Mekapogu A; Perera C; Murakami T; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'Inhibition of Hepatocyte Growth Factor (HGF) Signaling Pathway in Combination With Chemotherapy Reduces Tumour Burden in an Orthotopic Model of Advanced Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1551 - 1551, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000505712800617&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Goldstein D, 2019, 'International volunteering through ASCO - a Vietnam experience', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maharaj A; Samoborec S; Evans SM; Zalcberg J; Neale RE; Goldstein D; Merrett N; White K; Croagh D; Pilgrim CHC; Evans P; Knowles BPF; Leong T; Philip J; Smith M; Ioannou L, 2019, 'Patient Reported Outcome Measures (PROMs) in pancreatic cancer: a systematic review', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. S57 - S57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000486499800130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Z; Pang T; Pothula S; Mekapogu A; Perera C; Murakami T; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'Inhibition of hepatocyte growth factor signaling pathway in combination with chemotherapy reduces tumor burden in an orthotopic model of advanced pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hayes SA; Martin A; Yip S; Howell VM; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Simes J; Goldstein D; Pavlakis N, 2019, 'Abstract 4531: SWATH-MS profiling identifies prognostic factors for progression-free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)', in Cancer Research, American Association for Cancer Research (AACR), pp. 4531 - 4531, http://dx.doi.org/10.1158/1538-7445.am2019-4531

Back to profile page